POST LEONARD E 4

What Happened
Leonard E. Post, a director of CG Oncology (CGON), exercised 5,000 options at $0.60 per share (cost $3,000) and sold 5,000 common shares in the open market at $70.00 per share for proceeds of $350,000. The filing also reports a related "derivative disposed" entry for 5,000 shares at $0.00 in connection with the exercise. The net economic effect was an option exercise followed by an immediate sale (routine monetization rather than a buy).

Key Details

• Transaction date: June 24, 2026.
• Exercise: 5,000 shares @ $0.60 = $3,000 (code M).
• Sale: 5,000 shares @ $70.00 = $350,000 (code S).
• Derivative disposition: 5,000 shares @ $0.00 reported (related to the exercise).
• Footnotes: Sales were made under a Rule 10b5-1 trading plan adopted March 5, 2026 (F1). Options were fully vested (F2).
• Shares owned after transaction: not stated in the filing.
• Filing timeliness: no late filing indicated in the report.

Context
This sequence—exercise of options and same-day sale—effectively converts option value to cash and is commonly done for tax or diversification reasons. The use of a Rule 10b5-1 plan indicates the sale was preplanned and routine; it does not on its own indicate a change in the director’s view of the company.